Retinal Biologics Market Segment Predictions: What the Future Holds

adicionou um novo artigo Health

2024-09-23 13:41:09 - Traduzir -

The Retinal Biologics Market Segment, valued at USD 22.5 billion in 2023, is projected to expand to USD 49.5 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period from 2024 to 2032. Retinal biologics are innovative therapeutic agents used to treat various retinal disorders, including age-related macular degeneration (AMD), diabetic retinopathy, and...

0 Comentários 0 Compartilhamentos 323 Visualizações 0 Anterior